$DCTH
Delcath Systems Inc

2017 Q2 Form 10-Q Financial Statement

#000156459017016205 Filed on August 08, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $584.0K $511.0K
YoY Change 14.29% 9.66%
Cost Of Revenue $140.0K $150.0K
YoY Change -6.67% 9.49%
Gross Profit $449.0K $361.0K
YoY Change 24.38% 9.73%
Gross Profit Margin 76.88% 70.65%
Selling, General & Admin $2.530M $2.287M
YoY Change 10.63% -8.59%
% of Gross Profit 563.47% 633.52%
Research & Development $2.518M $1.945M
YoY Change 29.46% 34.14%
% of Gross Profit 560.8% 538.78%
Depreciation & Amortization $100.0K $100.0K
YoY Change 0.0% -50.0%
% of Gross Profit 22.27% 27.7%
Operating Expenses $5.050M $4.232M
YoY Change 19.33% 7.09%
Operating Profit -$4.601M -$3.871M
YoY Change 18.86% 6.85%
Interest Expense -$6.950M -$1.180M
YoY Change 488.98% 2260.0%
% of Operating Profit
Other Income/Expense, Net $0.00 -$1.615M
YoY Change -100.0% 5667.86%
Pretax Income -$1.940M -$6.670M
YoY Change -70.91% 80.27%
Income Tax
% Of Pretax Income
Net Earnings -$1.943M -$6.667M
YoY Change -70.86% 80.24%
Net Earnings / Revenue -332.71% -1304.7%
Basic Earnings Per Share -$3.50 -$1.544K
Diluted Earnings Per Share -$0.01 -$4.41
COMMON SHARES
Basic Shares Outstanding 252.3M 1.511M
Diluted Shares Outstanding 252.3M 1.511M

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.820M $7.480M
YoY Change -75.67% -46.76%
Cash & Equivalents $1.816M $1.818M
Short-Term Investments
Other Short-Term Assets $14.13M $18.41M
YoY Change -23.25% 1573.64%
Inventory $1.040M $746.0K
Prepaid Expenses
Receivables $380.0K $363.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $17.37M $27.00M
YoY Change -35.67% 69.92%
LONG-TERM ASSETS
Property, Plant & Equipment $1.230M $1.062M
YoY Change 15.82% -29.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.33M
YoY Change
Total Long-Term Assets $1.230M $14.39M
YoY Change -91.45% 859.84%
TOTAL ASSETS
Total Short-Term Assets $17.37M $27.00M
Total Long-Term Assets $1.230M $14.39M
Total Assets $18.60M $41.39M
YoY Change -55.06% 138.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $990.0K $439.0K
YoY Change 125.51% -16.86%
Accrued Expenses $2.230M $2.035M
YoY Change 9.58% -1.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $12.60M $0.00
YoY Change
Total Short-Term Liabilities $17.21M $33.66M
YoY Change -48.86% 904.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $1.570M
YoY Change -100.0%
Other Long-Term Liabilities $530.0K $716.0K
YoY Change -25.98% -22.93%
Total Long-Term Liabilities $530.0K $716.0K
YoY Change -25.98% -22.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.21M $33.66M
Total Long-Term Liabilities $530.0K $716.0K
Total Liabilities $17.74M $35.96M
YoY Change -50.66% 740.53%
SHAREHOLDERS EQUITY
Retained Earnings -$269.7M
YoY Change 6.31%
Common Stock $15.00K
YoY Change -88.46%
Preferred Stock
YoY Change
Treasury Stock (at cost) $51.00K
YoY Change 0.0%
Treasury Stock Shares $110.00
Shareholders Equity $870.0K $5.430M
YoY Change
Total Liabilities & Shareholders Equity $18.60M $41.39M
YoY Change -55.06% 138.01%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income -$1.943M -$6.667M
YoY Change -70.86% 80.24%
Depreciation, Depletion And Amortization $100.0K $100.0K
YoY Change 0.0% -50.0%
Cash From Operating Activities -$4.320M -$3.150M
YoY Change 37.14% -30.77%
INVESTING ACTIVITIES
Capital Expenditures -$220.0K -$80.00K
YoY Change 175.0% 100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$1.060M
YoY Change -100.0%
Cash From Investing Activities -$220.0K -$1.140M
YoY Change -80.7% 2750.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -120.0K 2.260M
YoY Change -105.31% 1155.56%
NET CHANGE
Cash From Operating Activities -4.320M -3.150M
Cash From Investing Activities -220.0K -1.140M
Cash From Financing Activities -120.0K 2.260M
Net Change In Cash -4.660M -2.030M
YoY Change 129.56% -53.97%
FREE CASH FLOW
Cash From Operating Activities -$4.320M -$3.150M
Capital Expenditures -$220.0K -$80.00K
Free Cash Flow -$4.100M -$3.070M
YoY Change 33.55% -31.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1327000
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2518000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-14000
dcth Interest Income Earned On Money Market And Operating Accounts
InterestIncomeEarnedOnMoneyMarketAndOperatingAccounts
2000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-42000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
94000
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
150000
us-gaap Cost Of Revenue
CostOfRevenue
354000
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.41
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2287000
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1973000
us-gaap Depreciation
Depreciation
127000
us-gaap Depreciation
Depreciation
169000
dcth Interest Income Earned On Money Market And Operating Accounts
InterestIncomeEarnedOnMoneyMarketAndOperatingAccounts
1000
CY2017Q2 us-gaap Gross Profit
GrossProfit
449000
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.72
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1483148
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.72
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1510752
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
797000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
933000
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1510752
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
148722094
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1483148
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-170000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-104000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
95000
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
15831000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
19000
us-gaap Operating Income Loss
OperatingIncomeLoss
-8814000
CY2016Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1181000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1200000
CY2017Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
9613000
CY2016Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
9613000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Interest Expense
InterestExpense
15282000
us-gaap Interest Expense
InterestExpense
1631000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-1943000
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-30000
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
252264959
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
148674658
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
252264959
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
46000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
64000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
15498000
dcth Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
14000
dcth Fair Value Of Warrants Exercised
FairValueOfWarrantsExercised
19000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-8000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
46000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
114000
us-gaap Restricted Stock Expense
RestrictedStockExpense
64000
us-gaap Restricted Stock Expense
RestrictedStockExpense
190000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-20000
dcth Deferred Revenues
DeferredRevenues
2000
dcth Deferred Revenues
DeferredRevenues
19000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
15277000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1568000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-201000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
94000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
208000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
628000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-110000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8137000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6968000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
276000
us-gaap Increase In Restricted Cash
IncreaseInRestrictedCash
0
us-gaap Increase In Restricted Cash
IncreaseInRestrictedCash
1062000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-276000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1157000
dcth Increase In Restricted Cash From Financing Activities
IncreaseInRestrictedCashFromFinancingActivities
0
dcth Increase In Restricted Cash From Financing Activities
IncreaseInRestrictedCashFromFinancingActivities
29200000
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
5954000
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
31523000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
15000
CY2016Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
346000
CY2016Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
214000
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
100000
CY2016Q4 us-gaap Prepaid Insurance
PrepaidInsurance
501000
CY2016Q4 us-gaap Security Deposit
SecurityDeposit
50000
CY2016Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
147000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-149000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-25000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2593000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5123000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4409000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1818000
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
704000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5969000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3027000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
28133000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
245000
dcth Amount Of Minimum Stock Split Ratio
AmountOfMinimumStockSplitRatio
1000
CY2017Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
301000
CY2017Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
560000
CY2017Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
179000
CY2017Q2 us-gaap Prepaid Insurance
PrepaidInsurance
252000
CY2017Q2 us-gaap Security Deposit
SecurityDeposit
50000
CY2017Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
197000
CY2017Q2 dcth Maximum Percentage Of Prepaid Expenses And Other Current Assets
MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets
0.05
CY2016Q4 dcth Maximum Percentage Of Prepaid Expenses And Other Current Assets
MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets
0.05
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4913000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4886000
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3681000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3803000
CY2017Q2 us-gaap Depreciation
Depreciation
100000
CY2016Q2 us-gaap Depreciation
Depreciation
100000
CY2017Q2 dcth Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
1348000
CY2016Q4 dcth Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
1365000
CY2017Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
256000
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
286000
CY2017Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
221000
CY2016Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
216000
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
957000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
607000
CY2017Q2 dcth Maximum Percentage Of Current Liabilities Accrued
MaximumPercentageOfCurrentLiabilitiesAccrued
0.05
CY2016Q4 dcth Maximum Percentage Of Current Liabilities Accrued
MaximumPercentageOfCurrentLiabilitiesAccrued
0.05
CY2017Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.32
CY2017Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.20
CY2017Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.14
CY2017Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.11
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
170000000
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2017Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.06
CY2017Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.05
CY2013Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
81875
CY2013Q4 dcth Proceeds From Issuance Of Private Placement Gross
ProceedsFromIssuanceOfPrivatePlacementGross
7500000
CY2013Q4 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6900000
CY2015Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
153750
CY2015Q1 dcth Proceeds From Issuance Of Private Placement Gross
ProceedsFromIssuanceOfPrivatePlacementGross
2600000
CY2015Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2500000
CY2015Q3 us-gaap Partners Capital Account Units Sale Of Units
PartnersCapitalAccountUnitsSaleOfUnits
600000
CY2017Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.36
CY2017Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
1478318
CY2017Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
544000
CY2017Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
3045817
CY2017Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
126000
CY2017Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
4417830
CY2017Q2 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
3621286
CY2017Q2 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
1913915
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
21347166
CY2016Q3 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
0
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
600000
CY2015Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6000000
CY2016Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
425000
CY2016Q4 dcth Proceeds From Issuance Of Private Placement Gross
ProceedsFromIssuanceOfPrivatePlacementGross
1200000
CY2016Q4 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1100000
dcth Number Of Inputs Used For Valuation Of Warrants
NumberOfInputsUsedForValuationOfWarrants
6
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
18751000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
1200000
dcth Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Extinguishment Gain Loss Of Convertible Note Warrant
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExtinguishmentGainLossOfConvertibleNoteWarrant
17489000
CY2017Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
43000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
193988
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7488515

Files In Submission

Name View Source Status
0001564590-17-016205-index-headers.html Edgar Link pending
0001564590-17-016205-index.html Edgar Link pending
0001564590-17-016205.txt Edgar Link pending
0001564590-17-016205-xbrl.zip Edgar Link pending
dcth-10q_20170630.htm Edgar Link pending
dcth-20170630.xml Edgar Link completed
dcth-20170630.xsd Edgar Link pending
dcth-20170630_cal.xml Edgar Link unprocessable
dcth-20170630_def.xml Edgar Link unprocessable
dcth-20170630_lab.xml Edgar Link unprocessable
dcth-20170630_pre.xml Edgar Link unprocessable
dcth-ex311_9.htm Edgar Link pending
dcth-ex312_6.htm Edgar Link pending
dcth-ex321_8.htm Edgar Link pending
dcth-ex322_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending